About NAYA Biosciences - Company Information, Overview, History and Profile
What does NAYA Biosciences do?
NAYA Biosciences Inc is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health. Its portfolio of assets currently includes NY-303, a GPC3 x NKp46 bifunctional antibody for the treatment of hepatocellular carcinoma (HCC) with a mode of action targeting non-responders to the current immunotherapy standard of care.
NAYA Biosciences Management structure
All Gross Remunerations are in USD
Mr. Steven M. Shum
Director and Chief Executive Officer
260 K
2024
Gross Remuneration
Year
Mr. Andrea Goren
Chief Financial Officer and Principal Accounting Officer
215 K
2024
Gross Remuneration
Year
Mr. Michael J. Campbell
Chief Operating Officer and Vice President, Business Development